Month: June 2020

GAITHERSBURG, Md., June 16, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following virtual investor conferences this month:BMO 2020 Prescriptions for Success Healthcare Virtual ConferenceJune 23 – fireside chat at 3:00 pm easternThree Part Advisors Virtual East Coast IDEAS Investor ConferenceJune 24 – pre-recorded presentation available for playback all day beginning at 8:00 am easternFor these conferences, the company’s webcast presentation may include a discussion of the company’s recent business developments as well as its financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”About Emergent BioSolutionsEmergent...

NEW YORK, June 16, 2020 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) (“Progenics”), an oncology company developing innovative medicines and artificial intelligence to find, fight and follow cancer, announced that at a special meeting of its stockholders held earlier today, Progenics’ stockholders voted to approve its proposed merger with Lantheus Holdings, Inc. (“Lantheus”), a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, by adopting the previously announced Amended and Restated Agreement and Plan of Merger, dated as of February 20, 2020 (the “Merger Agreement”), by and among Progenics, Lantheus and Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (“Merger Sub”), pursuant to which Merger Sub will be merged with and into Progenics...

NESS ZIONA, Israel, June 16, 2020 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced the company will present at the BMO 2020 Prescriptions for Success Healthcare Conference.        A live audio webcast will be available in the Investors/Events & Presentations section of the Sol-Gel Technologies website at http://ir.sol-gel.com/events-and-presentations. The webcast replay will also be available at the same link shortly after the conclusion of the event for 30 days.About Sol-Gel TechnologiesSol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and...

ALLEN, Texas, June 16, 2020 (GLOBE NEWSWIRE) — PFSweb, Inc. (NASDAQ: PFSW), a global commerce services company, will be presenting at the East Coast IDEAS Virtual Investor Conference, which is being held June 23-24, 2020. The presentation is scheduled to be available on Wednesday, June 24th starting at 8:00 a.m. Central time. It can be accessed here and via the investor relations section of the company’s website at www.pfsweb.com.For more information about the conference or to schedule a one-on-one meeting with PFSweb management, please contact your IDEAS conference representative or call the company’s investor relations team at 1-949-574-3860.About PFSweb, Inc.PFSweb (NASDAQ: PFSW) is a global commerce services company that manages the online customer shopping experience on behalf of major branded manufacturers and retailers....

FOSTER CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced the closing of its initial public offering of 17,968,750 shares of common stock, which includes the full exercise of the underwriters’ option to purchase 2,343,750 additional shares of common stock, at a public offering price of $16.00 per share. All of the shares were offered by Vaxcyte. The aggregate gross proceeds from the offering were $287.5 million, before deducting underwriting discounts and commissions and offering expenses. The shares began trading on the Nasdaq Global Select Market under the ticker symbol “PCVX” on June...

TEMPLE CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) — Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing solutions, today announced that it has launched an at-home testing solution for the Coronavirus Disease (COVID-19). The company has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for use in the United States.Fulgent Genetics will be offering the testing service through Picture Genetics, the company’s consumer-initiated genetic testing platform, beginning next week. Individuals interested in ordering testing services must qualify for the service through an online eligibility screener, which makes eligibility determinations based on current CDC guidelines while prioritizing those who are most in need of testing. Eligible...

TORONTO, June 16, 2020 (GLOBE NEWSWIRE) — WPT Industrial Real Estate Investment Trust (the “REIT”) (TSX: WIR.U; WIR.UN – OTCQX: WPTIF) announced today the results of voting for trustees at its annual meeting of unitholders held earlier today (the “Meeting”) and provided an operational update.VOTING RESULTSEach of the nominees listed in the management information circular dated May 13, 2020 was elected as a trustee of the REIT at the Meeting. On a vote conducted by ballot, the voting results were:Details of the voting results on all matters considered at the Meeting are available in the REIT’s report of voting results, which is available under the REIT’s profile on SEDAR at www.sedar.com.OPERATIONAL UPDATEThe REIT continues to closely monitor developments regarding the COVID-19 pandemic and work proactively to provide tenants...

MONTREAL, June 16, 2020 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will host its 2020 Annual Meeting of Shareholders (“Meeting”) on June 18, 2020 at 10:30 EDT in a virtual format due to the ongoing public health concerns related to the COVID-19 pandemic. The Corporation previously announced in its 2020 Notice of Meeting that, subject to public health conditions and concerns, it would host a hybrid Meeting format, whereby registered shareholders and duly appointed proxyholders could attend and participate either in person or via a live webcast. However, given the continued risks associated with hosting gatherings during the COVID-19 pandemic, the Company has made the decisions to adopt a pure virtual format with no in-person participation.Bombardier therefore welcomes all registered shareholders and duly appointed proxyholders who...

MONTRÉAL, 16 juin 2020 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) tiendra son assemblée annuelle des actionnaires 2020 (« Assemblée ») le 18 juin à 10 h 30 HAE en format virtuel en raison de la poursuite des préoccupations de santé publique liées à la pandémie de COVID-19.L’entreprise avait annoncé antérieurement dans son avis de convocation à l’Assemblée 2020 qu’en raison des conditions et des préoccupations de santé publique, elle tiendrait son Assemblée en un format hybride où les actionnaires inscrits et les fondés de pouvoir dûment nommés pourraient participer à l’Assemblée soit en personne soit en ligne sur Internet via une webdiffusion en direct. Toutefois, en raison de la poursuite des risques associés à la pandémie de COVID-19, l’entreprise a pris la décision d’adopter un pur format virtuel sans aucune participation en...

                            Citrine Global Corp., offering multi-strategy expansion solutions for growth-stage technology companies, participates in an exclusive funding round in Nanomedic, an Israeli medical company with unique technology of nanofiber ‘skin’ that revolutionizes wound care treatment (https://youtu.be/rqKqTIgXZT8)Citrine Global is currently trading as TechCare Corp. (TECR). Its name change to “Citrine Global Corp.” is expected to take effect soon.Tel Aviv, Israel, June 16, 2020 (GLOBE NEWSWIRE) — The board of directors of Citrine Global Corp. (OTCQB: TECR), approved, on June 10, 2020, an investment in Nanomedic Technologies Ltd., an Israeli company, through participation in an exclusive funding round open only to existing Nanomedic shareholders and their affiliates. Citrine Global decided to participate...